The Subcutaneous Implantable Cardioverter-Defi brillator:A Practical Review and Real-World Use and Application  

作　　者：Mark E.Panna Jr,MD,FACC,FHRS William M.Miles,MD,FACC,FHRS 

机构地区：[1]Division of Cardiology,Department of Medicine,North Florida/South Georgia Veterans Affairs Hospital,Gainesville,FL,USA [2]Section of Electrophysiology,Division of Cardiology,Department of Medicine,University of Florida,FL,USA

出　　处：《Cardiovascular Innovations and Applications》2016年第B02期199-209,共11页心血管创新与应用（英文）

摘　　要：The subcutaneous implantable cardioverter-defi brillator(ICD)is a novel technology using a subcutaneous(extrathoracic)system for treatment of potential lethal ventricular arrhythmias.It avoids many of the risks of transvenous ICD implantation.It may be considered in patients having an ICD indication who do not have a pacing and/or cardiac resynchronization therapy indication,and who are unlikely to benefi t from antitachycardia pacing therapy.We review patient selection,system components,the implantation technique,and screening considerations for subcutaneous ICD implantation.Its uses in specific patient populations,including children,patients with congenital heart disease,hypertrophic cardiomyopathy,or end-stage renal disease,and patients with preexisting pacemakers,are highlighted.Areas of future investigation are reviewed,including potential use with leadless pacing and magnetic resonance imaging.

关 键 词：SUBCUTANEOUS IMPLANTABLE cardioverter-defi brillator SUDDEN CARDIAC DEATH 

分 类 号：R[医药卫生]